OMS360: Shore Capital's Oral Surgery Platform, Mapped

Four years after Shore Capital Partners stitched together seven oral surgery practices in Kentucky, Alabama, and Georgia, OMS360 has quietly become one of the more disciplined specialty consolidators in dentistry — a nine-state oral and maxillofacial surgery platform that talks less about deal count and more about time-and-motion studies. For investors tracking the OMS consolidation wave, the Cumming, Georgia-based company is a useful case study in what a sponsor-built, integration-first platform looks like in its scaling phase.

Overview

OMS360 is an oral and maxillofacial surgeon support organization — the specialty-DSO equivalent of an MSO — headquartered in Cumming, Georgia, north of Atlanta.¹ The company was formed by Chicago-based private equity firm Shore Capital Partners — founding partnerships closed in December 2021, with the platform publicly announced in February 2022 — through simultaneous partnerships with two founding groups: Kentucky Center for Oral and Maxillofacial Surgery (KCOMS) and Community Oral Facial Surgery (COFS), which together contributed seven practices across Kentucky, Alabama, and Georgia.²

OMS360 was the second platform investment out of Shore Capital Partners Healthcare Fund IV, L.P., a $366 million vehicle raised in July 2021.² Shore remains the owner-of-record sponsor as of mid-2026, and the platform added a layer of institutional debt in May 2025 through a growth recapitalization with TPG Twin Brook Capital Partners.³

The company competes in a crowded specialty niche alongside platforms like US Oral Surgery Management, Allied OMS, and Beacon Oral Specialists, but it has staked out a distinct identity: CEO Trevor Maurer describes the strategy as "integration over aggregation" — growing partner practices organically through a proprietary playbook rather than racing to accumulate locations.⁴

Company Snapshot

• Company: OMS360
• Headquarters: Cumming, Georgia (410 Peachtree Parkway, Suite 4200)
• Founded: Announced February 2, 2022 (founding partnerships closed December 2021)
• Founder / Sponsor: Shore Capital Partners (Healthcare Fund IV, L.P. — $366 million, raised July 2021)
• CEO: Trevor Maurer (also an operating partner at Shore Capital)
• Chief Clinical Officer: Dr. Joshua Everts, DDS, MD (founding physician partner)
• Specialty focus: Oral and maxillofacial surgery exclusively
• Footprint: Partner practices across nine states — Alabama, Florida, Georgia, Kentucky, Michigan, Missouri, Pennsylvania, Tennessee, and Texas (company-reported, June 2026)
• Debt partner: TPG Twin Brook Capital Partners (credit facility, May 2025)
• Business model: MSO support — operations, marketing and referral management, revenue cycle, finance, HR and payroll, compliance, technology, and doctor recruiting; surgeons co-invest alongside the sponsor
• Operating playbook: Proprietary "360 Operating System" (360 OS)

Footprint Analysis

OMS360 does not publish a consolidated count of partner practices, offices, or surgeons, so any footprint estimate deserves care. What the company does disclose is state coverage: as of June 2026, the partner network spans nine states — Alabama, Florida, Georgia, Kentucky, Michigan, Missouri, Pennsylvania, Tennessee, and Texas.¹

The building blocks that have been announced publicly give a sense of scale. The founding transaction contributed seven practices across three states.² The June 2022 addition of Texas Oral Surgery Group brought four north-Texas practices in Plano, Denton, Decatur, and Gainesville.¹ Pittsburgh Oral Surgery, added in May 2025, operates four locations across the Pittsburgh metro.³ Founding anchor KCOMS alone fields seven board-certified surgeons across three Kentucky locations, and Greater St. Louis Oral and Maxillofacial Surgery — the Missouri entry that closed in late 2025 — brought a five-surgeon team.¹ Summing announced deals suggests a network of roughly 15 to 20 partner practices and a larger number of individual offices, but that is a TMR estimate assembled from disclosures, not a company-reported figure — and it is worth remembering that a "practice" here can mean anything from a single-surgeon office to a multi-site group.

Geographically, the platform is anchored in the Southeast — consistent with its founding thesis of becoming a preeminent support organization across the South and Mid-Atlantic — and has since pushed north (Michigan, Pennsylvania) and west (Missouri, Texas).² That Southeast concentration is notable because, by the CEO's own estimate, oral surgery in the Southeast is already roughly low-20% consolidated versus high-teens nationally, meaning OMS360's home region is among the more competitive hunting grounds for new affiliations.⁴

Growth History

OMS360's timeline reads as deliberate rather than frenetic — a handful of carefully chosen partnerships per year rather than a location-count sprint:

• February 2022 — Shore Capital founds OMS360 through partnerships with KCOMS and COFS: seven practices across Kentucky, Alabama, and Georgia. Trevor Maurer, an experienced multi-site healthcare executive, is installed as CEO.²
• June 2022 — Texas Oral Surgery Group joins, adding four practices in north Texas and marking the platform's fourth state.¹
• 2023–2024 — The company builds out its executive bench: Burake Taye joins as chief strategy, operations, and technology officer (September 2023), and founding doctor Dr. Joshua Everts is elevated to chief clinical officer. Expansion during this period extends the network into states including Michigan, Tennessee, and Florida, based on the state lists in later announcements.¹
• May 2025 — A two-part announcement: Pittsburgh Oral Surgery (four locations) becomes the platform's entry into Pennsylvania, its eighth state, and OMS360 completes a growth recapitalization anchored by a new credit facility — a revolving line plus a delayed-draw term loan — from TPG Twin Brook Capital Partners.³
• May–June 2025 — Winter Haven Oral Surgery, led by Dr. Rigo Cornejo, brings the platform into Central Florida.⁵
• Late 2025 — Greater St. Louis Oral and Maxillofacial Surgery joins, marking Missouri as the ninth state (announced June 2026).¹
• June 2026 — Two further partnerships announced alongside the Missouri disclosure: The Oral & Facial Surgery Center of Kentucky (Elizabethtown) and Center for Facial and Oral Surgery (Carrollton, Texas). The company also appoints Jamie Cassidy as chief growth officer, signaling an intent to accelerate development.¹

The TPG Twin Brook facility is the most investor-relevant milestone on that list. A delayed-draw term loan is purpose-built acquisition capital, and pairing it with a dedicated growth officer hire suggests the platform is positioning for a faster affiliation cadence in 2026 and beyond — while the "growth recapitalization" framing indicates Shore extended its hold rather than exiting.³

On performance, the company reports that mature partner practices have delivered approximately 20% annual collections growth and 67% cumulative growth under its 360 Operating System, and Maurer has separately cited low-to-mid-20% average annual organic growth across practices.⁴ Those figures are company-reported and unaudited, but even discounted they would be well above the low-single-digit growth Maurer attributes to the oral surgery market overall — the gap is the core of the platform's value-creation story.

Competitive Landscape

Oral surgery is one of the most actively consolidated specialties in dentistry, and OMS360 operates against a well-capitalized peer set. US Oral Surgery Management is the category's scale leader; Allied OMS competes on a doctor-equity governance model; Beacon Oral Specialists and MAX Surgical Specialty Management round out the dedicated OMS platforms — MAX notably secured a $77 million senior credit facility from Freeport Financial Partners in April 2025, weeks before OMS360 announced its TPG Twin Brook financing — a sign that lenders remain constructive on the specialty.⁵ Multi-specialty consolidators such as Specialty1 Partners also compete for the same surgeon affiliations.

Within that set, OMS360 differentiates on three axes. First, operating depth: the 360 Operating System, built on time-and-motion studies of the patient journey, is pitched as a genuine operating playbook rather than back-office outsourcing, organized around four focus areas — people, quality, delivery, and finance.⁴ Second, clinical governance: founding surgeons hold board seats and the CCO role, and founding doctor Dr. Bob Clark's 2025–26 term as AAOMS president gives the platform unusual standing inside the specialty's professional establishment.¹ Third, surgeon economics: the recruiting pitch emphasizes co-investment alongside the sponsor and long-term career pathways rather than pure employment.¹

The addressable market remains deep. Maurer estimates 6,500 to 9,000 oral surgery practices in the US, with national consolidation in the high teens — leaving the large majority of the specialty independent.⁴ The constraint is less supply than competition for the highest-quality groups, where several platforms are often courting the same practices.

Market Position

OMS360 today reads as a mid-sized specialty platform in transition from founding phase to scaling phase. It is smaller by location count than the category leader, based on available disclosures, but it has assembled the ingredients scaling requires: a repeatable operating system with company-reported results, an institutional credit facility with delayed-draw capacity, a full C-suite including a dedicated growth officer, and a sponsor in Shore Capital that has grown from roughly $12.5 billion to approximately $17 billion in assets under management during the hold.²

For Shore, a microcap-focused firm that typically builds platforms toward an eventual sale to a larger sponsor, OMS360 is now in the window where secondary-buyout speculation naturally begins. The 2025 transaction was a debt recapitalization, not an equity change of control — so the platform's next equity event remains ahead of it. A track record of ~20% company-reported organic growth in a specialty with durable demand (wisdom teeth, implants, facial trauma) and a fragmented supply base is precisely the profile mid-market healthcare buyers have paid up for in prior OMS processes.

The open questions are the ones disclosures cannot answer: actual consolidated revenue and EBITDA, same-practice performance net of the marketing spend behind it, and how affiliation multiples in the specialty have moved as more platforms compete for fewer flagship groups.

TMR Take: For operators, OMS360 is one of the more credible "sell without selling out" options in oral surgery — clinical governance is genuinely doctor-heavy, and the organic-growth playbook is the pitch, not a bolt-on. For vendors, a nine-state network standardizing operations under one 360 OS playbook is a concentrated buying center for imaging, anesthesia workflow, referral management, and revenue-cycle tooling — winning the platform means winning every partner practice. For investors, this is a Shore Capital platform entering its scaling window with fresh delayed-draw debt capacity and a new growth officer; watch the affiliation cadence over the next 12–18 months and any advisor engagement as the clearest signals of an approaching sponsor-to-sponsor process.

For more on how the oral surgery consolidation wave is unfolding, see our profiles of US Oral Surgery Management, Allied OMS, and MAX Surgical Specialty Management, or browse the full company-profile library in the TMR learning hub.

Sources

1. OMS360 — company website, press releases, and partnership announcements.

2. Shore Capital Partners — founding announcement and firm disclosures.

3. OMS360 and TPG Twin Brook Capital Partners — growth recapitalization and Pittsburgh Oral Surgery partnership announcement.

4. The Corner Series (McGuireWoods) — interview with OMS360 CEO Trevor Maurer.

5. Group Dentistry Now and DrBicuspid — DSO transaction coverage.